Abstract:Temozolomide (TMZ) is a common clinical drug widely used to treat glioblastoma multiforme and gradual astrocytoma. Despite its widespread use in cancer treatment, issues remain with the solubility and stability of TMZ, which can be addressed by synthesizing novel pharmaceutical cocrystals. This study sought to enhance the physiochemical properties of TMZ. To this end, a pioneering pharmaceutical cocrystal of TMZ and caffeic acid (CAF), 2TMZ–CAF·0.5H 2 O (2:1:0.5) was synthesized and characterized using a solution method. The cocrystal structure was analyzed by molecular surface electrostatic potential (MESP), Hirshfeld surface analysis, and 2D fingerprinting. They were further characterized by single crystal X-ray diffraction, power X-ray diffraction, proton nuclear magnetic resonance, thermogravimetry-differential scanning calorimetry, dynamic vapor sorption, and Fourier transform infrared spectroscopy. Furthermore, the hygroscopicity, stability, and solubility of the TMZ–CAF cocrystal were investigated to evaluate their pharmaceutical applicability. In the asymmetric unit of the novel synthesized cocrystal, two complementary molecules of TMZ and CAF were found, forming planar hydrogen bonding pairs such as O–H···O, N–H···O, and O–H···N. Moreover, the cocrystals exhibited excellent stability compared to TMZ alone and regulated solubility during accelerated stabilization and dissolution processes. Hence, the cocrystals boast characteristics that can circumvent the rapid release of TMZ. In conclusion, the newly synthesized 2TMZ–CAF·0.5H 2 O cocrystals demonstrate enhanced physiochemical properties, including improved stability and solubility, compared to pure TMZ. This suggests potential utility in drug delivery systems. Additionally, the findings underscore the growing importance of pharmaceutical cocrystals in drug development, with implications for advancing cancer treatment and drug formulation strategies.

Enhancing the hygroscopic stability of S-oxiracetam via pharmaceutical cocrystals

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

Three New Cocrystals Derived from Liquid Pyrazine Spices: X-ray Structures and Hirshfeld Surface Analyses

Tetramethylpyrazine Cocrystals with Cinnamic Acid and Its Derivatives: Crystal Structures, Theoretical Computations, and Sublimation Behavior Studies

Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations

Chemical stabilization strategy for cymoxanil: synthesis and characterization of cocrystals with small organic acids

Raman and terahertz spectroscopical investigation of cocrystal formation process of piracetam and 3-hydroxybenzoic acid

Using synchrotron high-resolution powder X-ray diffraction for the structure determination of a new cocrystal formed by two active principle ingredients

Construction of Interesting Organic Supramolecular Structures with Synthons Cooperation in the Cocrystals of 1H-Benzotriazole and Hydroxybenzoic Acids

Exploring the formation and diversity of secnidazole cocrystals

Improving Solubility and Avoiding Hygroscopicity of Tetrahydropalmatine by Forming a Pharmaceutical Salt Cocrystal via CAHBs

Co-Crystallization of Glycine Anhydride with the Hydroxybenzoic Acids: Controlled Formation of Dimers Via Synthons Cooperation and Structural Characterization

Studies on the Synthesis, Structural Characterization, Hirshfeld Analysis and Stability of Apovincamine (api) and Its Co-Crystal (terephthalic Acid: Apovincamine=1:2)

4 - Acetylpyridine - succinic acid cocrystal: Synthesis, X-ray structure, DFT and Hirshfeld surfaces analysis

A co-crystal strategy for the solidification of liquid pyrazine derivatives: X-ray structures and Hirshfeld surface analyses

The Discovery of New Cocrystals of 5-Fluorocytosine Using Amine–carboxylate Supramolecular Synthon

Cocrystals of carbamazepine: Structure, mechanical properties, fluorescence properties, solubility and dissolution rate

A Drug–Drug Cocrystal Strategy to Regulate Stability and Solubility: A Case Study of Temozolomide/Caffeic Acid

Cocrystals of Oxymatrine: Reducing Hygroscopicity and Affecting the Dissolution Rate

A Novel Cocrystal of Metformin Hydrochloride with Citric Acid: Systematic Synthesis and Computational Simulation

[Spectral Analysis about the Pharmaceutical Cocrystal Formation of Piracetam and 3-Hydroxybenzoic Acid]